Acetylsalicylic acid and sodium salicylate inhibit LPS-induced NF-κB/c-rel nuclear translocation, and synthesis of tissue factor (TF) and tumor necrosis factor alfa (TNF-α) in human monocytes

Thrombosis and Haemostasis

Volumn 76, Issue 6, 1996, Pages 970-976

  Osnes, L T N ^a   Foss, K B ^a   Joo G B ^a   Okkenhaug, C ^a   Westvik, A B ^a   Ovstebo R ^a   Kierulf, P ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MESSENGER RNA; PROSTAGLANDIN E2; SALICYLATE SODIUM; THROMBOPLASTIN; TUMOR NECROSIS FACTOR ALPHA; NONSTEROID ANTIINFLAMMATORY AGENT;

ANTICOAGULATION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; PROTEIN TRANSPORT; BIOSYNTHESIS; CELL CULTURE; METABOLISM; TRANSPORT AT THE CELLULAR LEVEL;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; BIOLOGICAL TRANSPORT; CELLS, CULTURED; HUMANS; MONOCYTES; NF-KAPPA B; SODIUM SALICYLATE; THROMBOPLASTIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030299975     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Weissmann G. The actions of NSAIDs. Hosp Pract 1991; 26: 60-76.
2. Patrono C. Aspirin as an antiplatelet drug. N Eng J Med 1994; 330: 1287-94.
3. Mitchell JA, Akarasereenont P, Thiemermann C, Flower RJ, Vane JR. Selectivity of nonsteroidal anti-inflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci USA 1993; 90: 11693-7.
4. Kopp E, Ghosh S. Inhibition of NF-kappa B by sodium salicylate and aspirin. Science 1994; 265: 956-9.
5. Müller JM, Ziegler-Heitbrock HWL, Baeuerle PA. Nuclear factor kappa B, a mediator of lipopolysaccaride effects. Immunobiology 1993; 187: 233-56.
6. Edgington TS, Mackman N, Fan ST, Ruf W. Cellular immune and cytokine pathways resulting in tissue factor expression and relevance to septic shock. Nouv Rev Fr Hematol 1992; 34: S15-S27.
7. Schwager I, Jungi TW. Effect of human recombinant cytokines on the induction of macrophage procoagulant activity. Blood 1994; 83: 152-60.
8. Rus HG, Niculescu F, Vlaicu R. Tumor necrosis factor-alpha in human arterial wall with atherosclerosis. Atherosclerosis 1991; 89: 247-54.
9. Ramshaw AL, Roskell DE, Parums DV. Cytokine gene expression in aortic adventitial inflammation associated with advanced atherosclerosis (chronic periaortitis). J Clin Pathol 1994; 47: 721-7.
10. McVey JH. Tissue factor pathway. Baillieres Clin Haematol 1994; 7: 469-84.
11. Ruf W, Edgington TS. Structural biology of tissue factor, the initiator of thrombogenesis in vivo. FASEB J 1994; 8: 385-90.
12. Renz H, Gong JH, Schmidt A, Nain M, Gemsa D. Release of tumor necrosis factor-alpha from macrophages. Enhancement and suppression are dose-dependently regulated by prostaglandin E2 and cyclic nucleotides. J Immunol 1988; 141: 2388-93.
13. Kunkel SL, Spengler M, May MA, Spengler R, Larrick J, Remick D. Prostaglandin E2 regulates macrophage-derived tumor necrosis factor gene expression. J Biol Chem 1988; 263: 5380-4.
14. Zhong WW, Burke PA, Drotar ME, Chavali SR, Forse RA. Effects of prostaglandin E2, cholera toxin and 8-bromo-cyclic AMP on lipopolysaccharide-induced gene expression of cytokines in human macrophages. Immunology 1995; 84: 446-52.
15. Williams JG, Garcia I, Maier RV. Prostaglandin E2 mediates lipopolysaccharide-induced macrophage procoagulant activity by a cyclic adenosine monophosphate-dependent pathway. Surgery 1993; 114: 314-23.
16. Sitrin RG, Kaltreider HB, Goldyne ME. Prostaglandin E is required for the augmentation of procoagulant activity of LPS-stimulated rabbit alveolar macrophages. J Immunol 1984; 132: 867-71.
17. Osnes LTN, Westvik Å-B, Joø GB, Okkenhaug C, Kierulf P. Sodium salicylate inhibits lipopolysaccharide induced tissue factor (TF)- and tumor necrosis factor (TNF-α)-synthesis in vitro. Thromb Haemost 1995; 73: 694 (Abstract).
18. Brandtzæg P, Kierulf P, Gaustad P, Skulberg A, Bruun J, Halvorsen S, Sørensen E. Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. J Infect Dis 1989; 159: 195-204.
19. Osnes LT, Westvik AB, Kierulf P. Procoagulant and profibrinolytic activities of cryopreserved human monocytes. Thromb Res 1994; 76: 373-83.
20. Osnes LTN, Westvik ÅB, Øvstebø R, Joø GB, Okkenhaug C, Kierulf P. Lipopolysaccharide activation of human monocytes mediated by CD14 results in a coordinated synthesis of tissue factor, TNF-α and IL-6. J Endotox Res 1995; 2: 27-35.
21. Oeth PA, Parry GCN, Kunsch C, Nantermet P, Rosen CA, Mackman N. Lipopolysaccharide induction of tissue factor gene expression in monocytic cells is mediated by binding of c-Rel/p65 heterodimers to a κB-like site. Mol Cell Biol 1994; 14: 3772-81.
22. Oeth P, Mackman N. Salicylates inhibit lipopolysaccharide-induced transcriptional activation of the tissue factor gene in human monocytic cells. Blood 1995; 86: 4144-52.
23. Liou HC, Baltimore D. Regulation of the NF-kappa B/rel transcription factor and I kappa B inhibitor system. Curr Opin Cell Biol 1993; 5: 477-87.
24. Collins T, Read MA, Neish AS, Whitley MZ, Thanos D, Maniatis T. Transcriptional regulation of endothelial cell adhesion molecules: NF-kB and cytokine-inducible enhancers. FASEB 1995; 9: 899-9.
25. Lo SK, Zheng Q, Silverstein RL. Induction of tissue factor on monocytes by adhesion to endothelial cells. J Immunol 1995; 154: 4768-77.
26. Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS. Role of transcriptional activation of IkBa in mediation of immunosuppression by glucocorticoid. Science 1995; 270: 283-6.
27. Auphan N, Didonato JA, Rose C, Helmberg A, Karin M. Immunosuppression by glucocorticoids. Inhibition of NF-kB activity through induction of IkB synthesis. Science 1995; 270: 286-90.
28. Frantz B, O'Neill EA. The effect of sodium salicylate and aspirin on NF-kB. Science 1995; 270: 2017-8.
29. Yasui K, Becker EL, Sha'afi RI. Lipopolysaccharide and serum cause the translocation of G-protein to the membrane and prime neutrophils via CD14. Biochem Biophys Res Commun 1992; 183: 1280-6.
30. Tanke T, van de Loo JW, Rhim H, Leventhal PS, Proctor RA, Bertics PJ. Bacterial lipopolysaccharide-stimulated GTPase activity in RAW 264.7 macrophage membranes. Biochem J 1991; 277: 379-385.
31. Vane JR, Flower RJ, Botting RM. History of aspirin and its mechanism of action. Stroke 1990; 21: IV12-IV23.
32. Gong JH, Renz H, Sprenger H, Nain M, Gemsa D. Enhancement of tumor necrosis factor-alpha gene expression by low doses of prostaglandin E2 and cyclic GMP. Immunobiology 1990; 182: 44-55.
33. Østerud B, Olsen JO, Wilsgard L. Increased lipopolysaccharide-induced tissue factor activity and tumour necrosis factor production in monocytes after intake of aspirin: possible role of prostaglandin E2. Blood Coagul Fibrinolysis 1992; 3: 309-13.
34. Osnes LTN, Westvik Å-B, Joø GB, Okkenhaug C, Kierulf P. Inhibition of IL-1 induced tissue factor (TF) synthesis and procoagulant activity (PCA) in purified human monocytes by IL-4, IL-10 and IL-13. Cytokine 1996 (Accepted).
35. Reinecker HC, Steffen M, Witthoeft T, Pflueger I, Schreiber S, MacDermott RP, Raedler A. Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin Exp Immunol 1993; 94: 174-81.
36. Brennan FM, Maini RN, Feldmann M. TNF alpha - a pivotal role in rheumatoid arthritis? Br J Rheumatol 1992; 31: 293-8.
37. Ridderstad A, Abedi-Valugerdi M, Moller E. Cytokines in rheumatoid arthritis. Ann Med 1991; 23: 219-23.
38. Vecchi M, Cattaneo M, de Franchis R, Mannucci PM. Risk of thrombo-embolic complications in patients with inflammatory bowel disease. Study of hemostasis measurements. Int J Clin Lab Res 1991; 21: 165-70.
39. Falk E, Fernandez-Ortiz A. Role of thrombosis in atherosclerosis and its complications. Am J Cardiol 1995; 75: 3B-11B.
40. Weinberg JB, Pippen AM, Greenberg CS. Extravascular fibrin formation and dissolution in synovial tissue of patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum 1991; 34: 996-1005.